Granules India (BOM:532482) Cyclically Adjusted Revenue per Share: ₹168.38 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532482 Granules India Ltd BOM:532482
81 GF Score
Price ₹831.25
GF Value ₹645.81
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Granules India Cyclically Adjusted Revenue per Share?

Granules India BOM:532482 -0.76% 81 Cyclically Adjusted Revenue per Share is ₹168.38 as of Jun. 2026. GuruFocus rates BOM:532482 with a GF Score™ of 81/100 and a GF Value™ of ₹645.81 (Modestly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Granules India's adjusted revenue per share for the three months ended in Jun. 2026 was ₹57.960. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹168.38 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Granules India's average Cyclically Adjusted Revenue Growth Rate was 13.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Granules India was 14.00% per year. The lowest was 11.30% per year. And the median was 13.10% per year.

As of today (2026-09-03), Granules India's current stock price is ₹831.25. Granules India's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹168.38. Granules India's Cyclically Adjusted PS Ratio of today is 4.94.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Granules India was 5.28. The lowest was 2.35. And the median was 3.46.


Granules India  (BOM:532482) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Granules India's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=831.25/168.38
=4.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Granules India was 5.28. The lowest was 2.35. And the median was 3.46.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Granules India Cyclically Adjusted Revenue per Share Related Terms


Granules India Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Granules India's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Granules India Cyclically Adjusted Revenue per Share Chart

Granules India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 99.70 117.44 132.08 144.21 161.98

Granules India Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 148.71 153.68 157.92 161.98 168.38

BOM:532482 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Granules India's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Granules India Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Granules India's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Granules India's Cyclically Adjusted PS Ratio falls into.


BOM:532482
81GF Score
Granules India Ltd BOM:532482
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Granules India Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Granules India's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=57.96/167.3573*167.3573
=57.960

Current CPI (Jun. 2026) = 167.3573.

Granules India Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 13.344 105.961 21.076
201612 16.003 105.196 25.459
201703 16.178 105.196 25.738
201706 16.413 107.109 25.645
201709 17.031 109.021 26.144
201712 16.188 109.404 24.763
201803 19.720 109.786 30.061
201806 17.763 111.317 26.706
201809 22.749 115.142 33.065
201812 24.720 115.142 35.930
201903 22.236 118.202 31.483
201906 23.384 120.880 32.375
201909 27.458 123.175 37.307
201912 27.597 126.235 36.587
202003 21.413 124.705 28.737
202006 28.777 127.000 37.921
202009 34.402 130.118 44.248
202012 33.940 130.889 43.396
202103 30.479 131.771 38.710
202106 34.149 134.084 42.623
202109 35.675 135.847 43.950
202112 40.017 138.161 48.474
202203 39.992 138.822 48.213
202206 41.000 142.347 48.204
202209 46.158 144.661 53.400
202212 47.014 145.763 53.979
202303 48.696 146.865 55.491
202306 40.742 150.280 45.372
202309 49.095 151.492 54.237
202312 47.397 152.924 51.870
202403 48.170 153.035 52.678
202406 48.720 155.789 52.338
202409 39.448 157.882 41.815
202412 46.747 158.323 49.415
202503 49.359 157.552 52.431
202506 49.796 159.755 52.166
202509 53.331 162.289 54.996
202512 56.786 163.281 58.204
202603 59.507 164.272 60.624
202606 57.960 167.357 57.960

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹168.38 mean?
Granules India (BOM:532482) has a Cyclically Adjusted Revenue per Share of ₹168.38 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Granules India and its competitors.
Is Granules India's Cyclically Adjusted Revenue per Share too high?
Granules India's current Cyclically Adjusted Revenue per Share is ₹168.38. Overall, Granules India has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Granules India's Cyclically Adjusted Revenue per Share compare to ZTS?
Granules India's Cyclically Adjusted Revenue per Share of ₹168.38 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Granules India and its competitors. Granules India's current Cyclically Adjusted Revenue per Share is ₹168.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Granules India stock overvalued right now?
Based on GuruFocus' analysis, Granules India (BOM:532482) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹645.81, compared to a current price of ₹831.25 — trading 28.7% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹168.38. Granules India's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Granules India (BOM:532482), the current Cyclically Adjusted Revenue per Share is ₹168.38 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Granules India (BOM:532482) Overvalued in 2026?

Based on GuruFocus' analysis, Granules India stock appears to be overvalued. The current stock price of ₹831.25 is trading 28.7% above its estimated GF Value™ of ₹645.81. GuruFocus considers Granules India to be Modestly Overvalued.

Key valuation signals for BOM:532482:

  • Cyclically Adjusted Revenue per Share: ₹168.38
  • GF Value™: ₹645.81 vs. price of ₹831.25 (28.7% above fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the BOM:532482 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Granules India Business Description

Other Exchanges GRANULES:India
Address Botanical Garden Road, 15th Floor, Granules Tower, Kondapur, Hyderabad, TG, IND, 500084
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and the Rest of the World. The company generates a majority of its revenue from its business outside India.
81GF Score

Get the complete analysis for BOM:532482

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹831.25
Price
₹645.81
GF Value